2023
DOI: 10.1016/j.jpha.2023.05.005
|View full text |Cite
|
Sign up to set email alerts
|

Ginsenoside Rk2, a dehydroprotopanaxadiol saponin, alleviates alcoholic liver disease via regulating NLRP3 and NLRP6 inflammasome signaling pathways in mice

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 10 publications
(2 citation statements)
references
References 59 publications
0
2
0
Order By: Relevance
“…The weights of the mice were recorded at a set time each day. The changes in food intake, water consumption, mental state observe and record the behavioral activities of each group of mice (Zou et al, 2023).…”
Section: General Observation Of Experimental Animalsmentioning
confidence: 99%
“…The weights of the mice were recorded at a set time each day. The changes in food intake, water consumption, mental state observe and record the behavioral activities of each group of mice (Zou et al, 2023).…”
Section: General Observation Of Experimental Animalsmentioning
confidence: 99%
“…Frequently, ALI initially manifests as fatty liver disease, which further develops into alcoholic steato-hepatitis, alcoholic hepatic fibrosis, and alcoholic cirrhosis. In particular, severe alcoholism may result in large-scale hepatocellular necrosis and even liver cancer [6,7]. Therefore, it is urgent to seek medicines or nutraceuticals to prevent and treat ALI and to elucidate their mechanisms of action.…”
Section: Introductionmentioning
confidence: 99%